Loading…
SBC Medical Group Holdings Incorporated is projected to rise to $3.45 by 2027, a +13% move from its current price of $3.06. SBC is currently trading below its 50-day average (a bearish sign). Technical indicators currently lean strong sell.
A data-driven summary — not financial advice. See the full breakdown below.
Live market data via Yahoo Finance · updated 8/2/2026
| Period | Min | Prediction | Max | Change |
|---|---|---|---|---|
| Aug 3 | $2.99 | $3.06 | $3.13 | +0.04% |
| Aug 4 | $2.97 | $3.06 | $3.16 | +0.07% |
| Aug 5 | $2.94 | $3.06 | $3.19 | +0.11% |
| Aug 6 | $2.93 | $3.06 | $3.21 | +0.14% |
| Aug 7 | $2.91 | $3.07 | $3.23 | +0.18% |
| Aug 8 | $2.90 | $3.07 | $3.24 | +0.21% |
| Aug 9 | $2.89 | $3.07 | $3.26 | +0.25% |
| Period | Min | Prediction | Max | Change |
|---|---|---|---|---|
| Week 1 | $2.89 | $3.07 | $3.26 | +0.25% |
| Week 2 | $2.82 | $3.08 | $3.35 | +0.50% |
| Week 3 | $2.78 | $3.08 | $3.42 | +0.75% |
| Week 4 | $2.74 | $3.09 | $3.49 | +0.99% |
| Week 5 | $2.71 | $3.10 | $3.55 | +1.25% |
| Week 6 | $2.68 | $3.11 | $3.60 | +1.50% |
| Week 7 | $2.65 | $3.11 | $3.65 | +1.75% |
Short-term targets derived from the forecast trend and recent volatility. Highly uncertain — not financial advice.
SBC Medical Group Holdings Incorporated, together with its subsidiaries, provides management services to cosmetic treatment centers in Japan, Vietnam, the United States, and Singapore. The company offers advertising and marketing services across social media networks; staff management services, such as recruitment and training; booking reservations for franchisee clinic customers; assistance with franchisee employee housing rentals; leasehold improvement services; and design services for clinics, medical equipment, and medical consumables procurement.
It also provides loyalty program management, labor and function supporting, and management consulting services; and IT software solutions, as well as engages in franchising activities; and distributes medical equipment and devices, implants, injection materials, other medical consumables, skin care and beauty products, and cosmetic products to franchisee clinics for resale to clinic customers. In addition, the company offers surgical and non-surgical surgeries that include breast augmentation; liposuction; rejuvenation treatments, such as treatment of wrinkles, acne, scars, cellulite, excess fat, discoloration, and signs of aging; laser skin toning and spot removal; eyes double fold surgery; rhinoplasty; treatment of osmidrosis and hyperhidrosis; hair transplants; gynecological formation treatments; laser hair removal; face line surgeries; cosmetical dental procedures; tattoo removal; lasik eye surgery; lateral canthoplasty; brow lift procedures; androgenetic alopecia treatment; and cheek sagging prevention methods. Further, it owns and operates treatment centers under the SBC brand.
SBC Medical Group Holdings Incorporated was founded in 2000 and is headquartered in Irvine, California.
SBC Medical Group Holdings Incorporated (SBC) is an Industrials sector stock with a current price of $3.19 per share and a market capitalization of $327.22M. It is ranked 3255 by market capitalization size. The stock operates a network of cosmetic treatment centers under the SBC brand and offers a wide range of management, distribution, and clinical services across several regions.
The price outlook reflects a near-term neutral stance in 2026, with an expected average price of $3.19, a minimum of $2.87, and a maximum of $4.38, and a 0% ROI. Over the longer horizon, the forecast shows a bullish trajectory, culminating in multi-year gains that project substantial upside by 2050.
Overall, the forecast indicates meaningful upside potential in the long run, with growing average prices and strong bullish sentiment in later years, though outcomes depend on market conditions and other factors outside the numerical projections.
A major floor 10.9% below — a decisive break under it would weaken the trend.
The nearest floor, 4.2% below — buyers have tended to step in here.
The nearest ceiling, 7.8% above — a clean break opens room to run.
A major ceiling 48.0% above — clearing it would confirm fresh momentum.
Key SBC support and resistance from recent price action — levels where the trend has historically paused or reversed. Percentages are the distance from the current price.
A snapshot of SBC market posture derived from its technical indicators and recent volatility. Higher trend and alignment lean bullish; higher risk means larger swings.
Technical Analysis
Indicators computed on daily closing prices.
| Period | SMA | Action | EMA | Action |
|---|---|---|---|---|
| MA 5 | $3.12 | Sell | $3.08 | Sell |
| MA 10 | $3.05 | Buy | $3.07 | Sell |
| MA 20 | $3.05 | Buy | $3.07 | Sell |
| MA 50 | $3.07 | Sell | $3.14 | Sell |
| MA 100 | $3.38 | Sell | $3.34 | Sell |
| MA 200 | $3.69 | Sell | $3.71 | Sell |
| Name | Value | Action |
|---|---|---|
| RSI (14) | 49.09 | Neutral |
| Stoch RSI (14) | 45.79 | Neutral |
| CCI (20) | 9.10 | Neutral |
| Williams %R (14) | -53.57 | Info |
| MACD (12,26,9) | 0.01 | Buy |
| ROC (12) | -0.65 | Sell |
| Bollinger %B (20,2) | 0.53 | Neutral |
| Stochastic %K (14) | 46.43 | Neutral |
| TRIX (15) | -0.03 | Sell |
| Awesome (5,34) | 0.06 | Buy |
| Ultimate (7,14,28) | 57.60 | Neutral |
| Momentum (10) | -0.02 | Sell |
| Aroon Osc (25) | -72.00 | Sell |
| Hull MA (9) | 3.12 | Sell |
| ADX (14) | 9.09 | Neutral |
| ATR (14) | 0.07 | Info |
The 30-day technical picture is bullish, with RSI(14) at 60 and the price around the SMA50 of $3.06. The near-term tone is supported by a price structure that sits above the 50-day moving average, suggesting moderate positive momentum.
The 30-day range runs from $2.66 to $3.83, with a defined support at $2.87 and a resistance at $3.30. The SMA200 sits at $3.72, providing a longer-term benchmark for price action and potential resistance moving forward.
| Year | Min | Avg | Max | ROI | Sentiment |
|---|---|---|---|---|---|
| $2.87 | $3.06 | $4.09 | 0% | Neutral | |
| $2.79 | $3.45 | $4.48 | +13% | Neutral | |
| $2.96 | $3.75 | $5.02 | +22% | Bullish | |
| $2.89 | $3.72 | $5.12 | +22% | Bullish | |
| $2.83 | $3.71 | $5.21 | +21% | Bullish | |
| $3.17 | $4.21 | $6.02 | +38% | Bullish | |
| $3.64 | $4.92 | $7.15 | +61% | Bullish | |
| $3.86 | $5.27 | $7.78 | +72% | Bullish | |
| $3.80 | $5.25 | $7.86 | +72% | Bullish | |
| $3.83 | $5.36 | $8.13 | +75% | Bullish | |
| $5.16 | $7.62 | $12.20 | +149% | Bullish | |
| $8.99 | $14.53 | $25.19 | +375% | Bullish |
Current year — the forecast is anchored to the live price, so ROI shows 0%.
| Month | Min | Avg | Max | Change |
|---|---|---|---|---|
| August 2026 | $2.87 | $3.06 | $3.79 | +0.00% |
| September 2026 | $2.71 | $3.19 | $3.85 | +4.33% |
| October 2026 | $2.67 | $3.16 | $3.85 | -1.01% |
| November 2026 | $2.72 | $3.23 | $3.97 | +2.33% |
| December 2026 | $2.77 | $3.31 | $4.09 | +2.47% |
Click any year to see its month-by-month SBC forecast. Min / Avg / Max are a bear / base / bull scenario; ROI is the projected move from the current price. Change is the month-over-month move in the average. Estimates, not guarantees.
By 2026, SBC could reach as high as $4.09, with a base case around $3.06 and support toward $2.87 — roughly 0% from $3.06. A consolidation phase looks the most probable path here.
Expect SBC to range from $2.79 to $4.48 through 2027. The $3.45 average target implies a +13% move from current prices. That is up +13% on the projected 2026 average. Price action looks broadly range-bound.
The SBC price prediction for 2028 points to an average of $3.75 (low $2.96, high $5.02) — a potential gain of +22% on today's $3.06. Buyers look set to stay in control over this stretch.
In 2029, SBC is projected to trade between $2.89 and $5.12, averaging $3.72 — a potential gain of +22% from today's $3.06. That is -1% versus the projected 2028 average. Momentum favours further upside here.
SBC Medical Group Holdings Incorporated's 2030 outlook centres on $3.71, within a $2.83 to $5.21 range. That is 0% versus the projected 2029 average. That marks a +21% change versus current levels. Buyers look set to stay in control over this stretch.
By 2031, SBC could reach as high as $6.02, with a base case around $4.21 and support toward $3.17 — roughly +38% from $3.06. Momentum favours further upside here.
Expect SBC to range from $3.64 to $7.15 through 2032. The $4.92 average target implies a +61% move from current prices. That is up +17% on the projected 2031 average. Buyers look set to stay in control over this stretch.
The SBC price prediction for 2033 points to an average of $5.27 (low $3.86, high $7.78) — a potential gain of +72% on today's $3.06. Momentum favours further upside here.
In 2034, SBC is projected to trade between $3.80 and $7.86, averaging $5.25 — a potential gain of +72% from today's $3.06. That is 0% versus the projected 2033 average. Buyers look set to stay in control over this stretch.
SBC Medical Group Holdings Incorporated's 2035 outlook centres on $5.36, within a $3.83 to $8.13 range. That is up +2% on the projected 2034 average. That marks a +75% change versus current levels. Momentum favours further upside here.
By 2040, SBC could reach as high as $12.20, with a base case around $7.62 and support toward $5.16 — roughly +149% from $3.06. Buyers look set to stay in control over this stretch.
Expect SBC to range from $8.99 to $25.19 through 2050. The $14.53 average target implies a +375% move from current prices. That is up +91% on the projected 2040 average. Momentum favours further upside here.
Investing $1,000 in SBC today (≈ 326.797386 SBC) could be worth
$4,747.42
+$3,747.42 (+375%) by 2050 · US Dollar
Based on the average projected SBC price of $14.53 in 2050.
Based on the base (average) forecast scenario. FX rates are indicative. Estimates only — not financial advice.
See what a past investment in SBCwould be worth at today's price.
$1,000 invested in SBC on Jul 31, 2025 (≈ 230.946886 SBC) would be worth
$706.7
-$293.3 (-29.3%) today · 0.71× · US Dollar
Based on a SBC entry price of $4.33 vs. today's $3.06.
| Invested | Entry price | Value today | Return |
|---|---|---|---|
| 1 week ago | $3.06 | $1,000 | +0.0% |
| 1 month ago | $3.17 | $965.3 | -3.5% |
| 3 months ago | $3.31 | $924.47 | -7.6% |
| 6 months ago | $4.92 | $621.95 | -37.8% |
| 1 year ago | $4.33 | $706.7 | -29.3% |
| All time (3.8y) ago | $9.96 | $307.23 | -69.3% |
Past performance from historical market data — it does not predict future results. FX rates are indicative. Not financial advice.
Enter a price to see how it sits against our SBC forecast.
Our base-case forecast reaches $6.10 around 2040.
Implied market cap at $6.10: $627.37M
In 2026, the average forecast price is $3.19, with a min of $2.87 and a max of $4.38, and an ROI of 0%, reflecting a neutral stance at the starting point of the projection. The outlook improves gradually, with 2027 averaging $3.63 (ROI 13.7%), 2028 averaging $4.02 (ROI 26.1%), and 2029 averaging $3.94 (ROI 23.4%), all bearing a neutral to bullish tilt.
From 2030 onward, the forecast turns progressively bullish: 2030 avg $3.90 (ROI 22.1%), 2031 avg $4.64 (ROI 45.6%), 2032 avg $5.48 (ROI 71.9%), 2033 avg $5.86 (ROI 83.7%), 2034 avg $5.84 (ROI 83), and 2035 avg $5.89 (ROI 84.5%), all marked as BULLISH. The longer-range horizon shows continued strength, with 2040 avg $8.67 (ROI 171.9%) and 2050 avg $17.02 (ROI 433.4%), both with a BULLISH sentiment, indicating substantial upside potential across the period.
Tap a question to reveal the answer.
The 2030 forecast shows an avg price of $3.90, a min of $2.88, and a max of $5.68, with ROI of 22.1% and a BULLISH sentiment.
The long-term projections indicate bullish potential, with rising averages and higher upside in later years (for example, 2028 avg $4.02 with ROI 26.1% and 2050 avg $17.02 with ROI 433.4%), though 2026 starts neutral and actual results can differ.
Yes. The 2040 forecast shows a max of $14.73 and an average of $8.67, with ROI 171.9% and a BULLISH sentiment.
The current price is $3.19 and the market capitalization is $327.22M.
For 2050 the forecast lists an average of $17.02, a min of $9.58, a max of $31.67, with ROI of 433.4% and a BULLISH sentiment.
SBC Medical Group Holdings Incorporated Community Discussion
0Share your SBC Medical Group Holdings Incorporated price prediction and read what the community thinks. Be respectful — comments are public and not financial advice.
Be the first to share your prediction…
What's your take? Add a comment above to start the conversation.